Tetracycline-reversible silencing of eukaryotic promoters
about
CHD1 and CHD2 are positive regulators of HIV-1 gene expressionTranscriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteinsSilencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Krüppel-type zinc finger factorCRISPR-mediated modular RNA-guided regulation of transcription in eukaryotesA novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteinsDoxycycline-regulated gene expression in the opportunistic fungal pathogen Aspergillus fumigatusMammalian chromodomain proteins: their role in genome organisation and expressionKRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreadingA possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptorsTransgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primatesAnaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpointThe cumate gene-switch: a system for regulated expression in mammalian cells.Improved single-chain transactivators of the Tet-On gene expression system.Synthetic tetracycline-inducible regulatory networks: computer-aided design of dynamic phenotypes.A new generation of pPRIG-based retroviral vectors.pBT, a novel vector for tetracycline-regulated yeast three-hybrid assayA transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor.Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.Highly conserved RNA sequences that are sensors of environmental stress.Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptorRegulatable systems: applications in gene therapy and replicating viruses.Cell-type specificity of short-range transcriptional repressors.A gene-rich, transcriptionally active environment and the pre-deposition of repressive marks are predictive of susceptibility to KRAB/KAP1-mediated silencing.Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesisConserved interaction between distinct Krüppel-associated box domains and the transcriptional intermediary factor 1 beta.Development of cell cultures that express hepatitis B virus to high levels and accumulate cccDNA.Flexible Accelerated STOP Tetracycline Operator-knockin (FAST): a versatile and efficient new gene modulating system.Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens.Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression.Specific micro RNA-regulated TetR-KRAB transcriptional control of transgene expression in viral vector-transduced cells.KRAB can repress lentivirus proviral transcription independently of integration site.Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factorsAAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.Development of a multipurpose GATEWAY-based lentiviral tetracycline-regulated conditional RNAi system (GLTR).Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes.Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE).Zinc finger transcription factors in skeletal development.
P2860
Q24305354-C4D418E1-D2B3-4FF1-8F29-042836CD4078Q24317298-85630BBA-0817-42ED-8C79-9091FB8FC7DDQ24324594-9E967B24-D707-4FEC-BA28-B88F349B6240Q24336617-35F6C343-9325-48C2-8482-626A944DCA00Q24625361-676E659B-9733-48B6-89A0-468AD0178B1EQ24654804-27D7E3E3-C7D4-4129-A6B2-4EF4B41BEE08Q24795519-AB18C075-4DA5-41A1-9AD4-13BF58D46EC6Q28143752-1AAC1A9D-3BC6-4D63-A2D0-FA21CD72B9A9Q28473103-2427BCB3-C468-4ED4-8DFF-E729B95177DCQ28504688-249DD907-104C-458B-94BB-5D1A176D93B8Q28543150-52B66976-1CE1-4A90-B536-79F79FDD3867Q28631721-A46AA1C2-A79D-4083-8277-365D0FE6EC9BQ33262655-1B3D6329-190B-4583-85EA-C63A8649997AQ33269863-97FE6D57-104F-4209-A294-44051195FBBEQ33281142-C61AC945-92E8-484C-948A-F8065ACED28AQ33308292-D8985159-ADBA-49EA-90F3-10ED85783F13Q33388913-27BE15B7-EB15-4057-BACB-A270ED12734FQ33451000-B043C1BF-E12B-44D1-98DC-2DF1A2A87AE1Q33680008-EE99396F-58FC-4B9D-95BB-EE7908602CB4Q33781775-29ADE4B7-3587-4EEB-8AED-6EE6CEFE92D6Q33887684-BF85A51B-B3A6-4E16-97A1-0F8BA4D125E6Q33888498-2338A493-E33B-4259-998B-5E122643374DQ33904282-D6D955D2-173A-4FD5-8A7C-3E2E608043F4Q33948988-1E73B562-5722-4F91-9F25-D73E4B7D7651Q33972163-ED92CBC8-0B5D-4AD9-B054-FE1849B10745Q34074553-40417FBE-7A64-4C32-9EB2-9A122C21E2DEQ34081078-E31A72BD-C43B-4E81-BE51-C87D48B81EE2Q34091587-0A4039EC-DED8-4DF7-BA78-58377EDD6663Q34263796-7C2B3F4C-9B18-46D7-A091-BA2D30888787Q34293285-0D710422-2A5B-4204-A699-7A6F3F4B49E8Q34445123-6D117FEE-D29E-4A44-A584-40012F978B11Q34517424-AB444FFB-967F-420A-8760-182CA70F1B2EQ34568487-C3049266-B6AB-49F3-A839-5BCB3BC5ABF3Q34761082-9E91B313-5FF4-4786-8E09-6D92781F3275Q35027496-FD5A7BCE-6F68-4BAE-BDAD-3BEBE1E78B61Q35170967-07F5EEE0-D77C-4137-A882-D363E707FB5AQ35180176-709FD1FD-AF5E-4C6C-9FDA-8D1D0A2331F1Q35182317-4B7C9D90-57D0-493E-9C29-DFE7FF6D37F9Q35205715-9EFD2768-E008-4A63-84F4-29C886EBB1EFQ35911349-716858F6-C7B5-4727-9031-AA6638A1E5B6
P2860
Tetracycline-reversible silencing of eukaryotic promoters
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Tetracycline-reversible silencing of eukaryotic promoters
@ast
Tetracycline-reversible silencing of eukaryotic promoters
@en
Tetracycline-reversible silencing of eukaryotic promoters
@nl
type
label
Tetracycline-reversible silencing of eukaryotic promoters
@ast
Tetracycline-reversible silencing of eukaryotic promoters
@en
Tetracycline-reversible silencing of eukaryotic promoters
@nl
prefLabel
Tetracycline-reversible silencing of eukaryotic promoters
@ast
Tetracycline-reversible silencing of eukaryotic promoters
@en
Tetracycline-reversible silencing of eukaryotic promoters
@nl
P2093
P2860
P356
P1476
Tetracycline-reversible silencing of eukaryotic promoters
@en
P2093
H J Thiesen
U Deuschle
P2860
P304
P356
10.1128/MCB.15.4.1907
P407
P577
1995-04-01T00:00:00Z